+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
The global cabazitaxel market size reached USD 297.1 million in 2021 and is projected to reach USD 344.75 million by 2031, with a CAGR of 5.15% during the forecast period.
Cabazitaxel, marketed as Jevtana, is a semi-synthetic derivative of a natural taxoid. It enriches microtubule stabilization, hindering cellular mitosis and division, and prevents androgen receptor signaling by binding cellular microtubules and dynein motor protein. Approved by the U.S. FDA in 2010 for hormone-refractory prostate cancer, it is also available as a generic medication.
Cabazitaxel is used to treat metastatic castration-resistant prostate cancer in men. It is administered when cancer has spread, even after treatments to prevent testosterone production or surgical testes removal.
Cabazitaxel, in combination with prednisone, is prescribed for metastatic castration-resistant prostate cancer post-docetaxel-based treatment. The treatment causes a reduction in plasma concentrations exhibiting triphasic kinetics.
The global COVID-19 pandemic has adversely affected the cabazitaxel market, leading to lower-than-anticipated/higher-than-anticipated demand compared to pre-pandemic levels. The anticipated spike in CAGR is attributed to the market's growth and demand returning to pre-pandemic levels post-pandemic.
COVID-19 disruptions include lockdowns, conversion of health institutions into testing centers, temporary halting of elective procedures, and manufacturing closures. The pandemic caused logistical challenges and patient reluctance to visit healthcare facilities, affecting the sale of cancer devices.
"Technological Advancements to Push Market Progress"
Factors such as prostate cancer incidence, technological advancements, and high unmet needs drive market growth. Increasing awareness of cancer and its treatment, especially for hormone-refractory prostate cancer, fuels the cabazitaxel market. Early-stage prostate cancer may not exhibit symptoms, but as it progresses, symptoms become apparent. Growing healthcare spending, government support, and awareness initiatives contribute to market development. Technical innovations in screening and tests, lifestyle changes, genomics, proteomics, and the aging population positively impact the market.
Request A Free Sample to learn more about this report
By Type
The market is segmented into Purity Above 99% and Other Purity.
By Application
Segmented by Age Below 65 and Age Above 65.
"Growing Incidences of Cancer to Drive Market Growth"
The rising number of prostate cancer patients and cardiac disorders drive market growth. Increased healthcare spending, government support, awareness initiatives, technical innovations, and lifestyle changes positively influence the market. Improvements in genomics, proteomics, the aging population, and the presence of new prostate cancer therapies intensify market growth.
"Targeted Therapies to Foster Market Progress"
Targeted therapy, focusing on specific genes or proteins in cancer cells, is rapidly advancing in cancer treatment research. Various types of targeted treatments, including gene expression modulators, hormone therapies, angiogenesis inhibitors, apoptosis inducers, and signal transduction inhibitors, are under study.
"High Cost to Impede Market Growth"
High therapy costs, uncertain reimbursement plans, and low life expectations restrain market growth. Premium pricing and undefined reimbursement plans deter people from treatment, impacting the market.
Request A Free Sample to learn more about this report
"North America to Govern Market Due to Rise in Cancer Patients"
North America holds the largest share of the global cabazitaxel market due to an increase in cancer patients. The U.S. is expected to have a substantial market share, driven by the prevalence of cancer, prominent players, research and development activities, and favorable reimbursement plans. Europe is also anticipated to have a sizable market share, with a focus on hormone therapy segments in the prostate cancer therapeutics market.
"Key Players to Boost Demand Leading to Market Growth"
Key players in the cabazitaxel market include Sanofi (France), Tapi Teva (Israel), Fuan Pharmaceutical Group (China), and Fujian Yewpark Biological (China).
In December 2020, EVER Pharma announced EU-wide marketing approval of Cabazitaxel for treating adult patients with metastatic prostate cancer. The new formulation allows safe treatment, saving time and costs compared to the existing two-vial system.
This comprehensive report profiles market players and analyzes factors such as segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. The analysis is subject to change based on key player actions and potential shifts in market dynamics.
The global cabazitaxel market size reached USD 297.1 million in 2021 and is projected to reach USD 344.75 million by 2031.
The global market is projected to grow at a CAGR of 5.15% during the forecast period, 2023-2032.
Research on the market is done by industry professionals who provide personalized insights on the industry structure, market segmentation, Type assessment, competitive landscape (CL), along with penetration, and emerging trends. In addition to years of professional experience in their various fields and sectors, their analysis is largely based on primary interview (60%) and secondary research (40%) as well as years of professional experience. In addition, our researchers forecast the market's direction over the following seven years by examining past trends and the market's current position. Additionally, various trends of segments and categories that are geographically portrayed are studied and estimated using primary and secondary research.
The key level executives (VP, CEO, Marketing Directors, and Business Development Managers) of the major industry participants who are active and prominent as well as mid-scale businesses operating in this market were interviewed in-depth for this supply-side report by overall Global Market Research.
Extensive primary research was conducted to gain a deeper grasp of the market and industry. Both primary and secondary research, as well as years of pertinent professional experience, are used to support the analysis. By analyzing past and present market patterns, our experts were able to forecast the market's course over the following seven years. For the geographically offered categories in the list of market tables, it differs per category. In connection with the Global Market research report, we also conducted a number of primary interviews with senior level executives (VP, CEO's, Directors, Marketing Directors, Business Development Managers, CFOs, Technical Consultants, Key Opinion Leaders, Industry Experts, Decision Matrix Authorities, and other crucial individuals) of the key industry players who dominated the Global market.
The primary purpose of secondary research was to gather, identify, and validate the information necessary for the thorough, technical, market-focused, and commercial analysis of the global market. With the use of this study, it was also possible to classify and segment the market in accordance with market trends, geographic markets, and regional considerations linked to market type. Analysts have gathered data in the Distribution Channel for the study of the market from reliable sources including annual reports, journals, white papers, corporate presentations, company websites, international organizations of Energy and Power manufacturers, credible paid databases, and many others to gather reliable intel.
Both top-down and bottom-up methodologies were employed to assess the accuracy of the global market size. The market for as a whole was estimated using these methods for a number of different dependent submarkets. Secondary research was used to address the major industry players, and primary and secondary research was used to calculate their market shares in the various regions. This complete intellectual process includes reading the annual and financial reports of the top market participants and conducting in-depth interviews with top industry executives (VP, CEO, Marketing Directors, and Business Development Managers) to gain important industry insights.
Through reliable secondary sources and validated primary sources, the classification of the global markets and their geographic percentage splits were established. To obtain the final qualitative and quantitative data, all relevant variables that might have an impact on the market under investigation have been taken into consideration, inspected in great depth, verified through primary research, and assessed. This information was collected, added to, and thoroughly examined by professional analysts before being provided in this report. The process used to estimate the overall market size for this study is depicted in the following image as an example.
Report Code :
RL65479
Published on :
Upcoming
Request a Free Sample Report
Speak to Analyst